Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BEETHOVEN phase 3 C. difficile vaccine study in adults aged 65 years and older
jRCT2031260066Phase 3Recruiting
- Sponsor
- Pfizer
- Start
- May 2026
01
Overview
Phase 3, randomised, double-blind trial in Clostridioides difficile colitis (CDI) (2 arms), sponsored by Pfizer. Primary endpoints: Percentage of participants reporting local reactions, Percentage of participants reporting systemic events and 5 more. Started May 2026; status: recruiting.
02
Conditions
Clostridioides difficile colitis (CDI)
Beyond the preview
Go deeper on jRCT2031260066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031260066.